aav2haqp1
Gene therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 30, 2015 (NCT02446249)
Timeline
Indications
Mechanism of action
- Aquaporin-4Supplementation
AQP4 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- aav2haqp1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05926765 | Phase 2 | Jun 13, 2023 | MeiraGTx |
| NCT04043104 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2019 | MeiraGTx |
| NCT02446249 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2015 | National Institute of Dental and Craniofacial Research (NIDCR) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MeiraGTx | For profit | 2 | 2 | 1 | 2019 |
| National Institute of Dental and Craniofacial Research (NIDCR) | Government | 1 | 1 | 1 | 2015 |
2 organizations
Page 1 / 1